300 related articles for article (PubMed ID: 17070141)
1. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.
Wu AH
Am Heart J; 2006 Nov; 152(5):828-34. PubMed ID: 17070141
[TBL] [Abstract][Full Text] [Related]
2. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
[TBL] [Abstract][Full Text] [Related]
3. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
4. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
Alehagen U; Goetze JP; Dahlström U
Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of patients with heart failure.
Mair J
Scand J Clin Lab Invest Suppl; 2005; 240():99-106. PubMed ID: 16112966
[TBL] [Abstract][Full Text] [Related]
6. [Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].
Ishii J
Rinsho Byori; 2008 Apr; 56(4):316-21. PubMed ID: 18516966
[TBL] [Abstract][Full Text] [Related]
7. BNP in the diagnosis and risk stratification of heart failure.
Moe GW
Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
[TBL] [Abstract][Full Text] [Related]
8. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
[TBL] [Abstract][Full Text] [Related]
9. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
Bettencourt P; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
[TBL] [Abstract][Full Text] [Related]
11. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
12. [Biomarkers in heart failure: BNP and NT-proBNP].
Ho CC; Liu CC
Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
15. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure.
Wu AH; Smith A
Eur J Heart Fail; 2004 Mar; 6(3):355-8. PubMed ID: 14987588
[TBL] [Abstract][Full Text] [Related]
16. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
17. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
Troughton RW; Richards AM
Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.
Araújo JP; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Am J Cardiol; 2006 Nov; 98(9):1248-50. PubMed ID: 17056340
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
